£1.5M
The round was led by Waseda University Ventures to support clinical studies and regulatory approval for the device.
"We have a strong base of evidence that neuroplasticity can be induced by detecting a motor command and applying artificial sensory feedback – guiding the brain to remake connections. Neubond has made rapid progress in translating this laboratory science into a simple device that patients can use at home"